Aqr Capital Management LLC United Therapeutics Corp Transaction History

Aqr Capital Management LLC

  • $58.2 Billion
  • Q1 2024

A detailed history of Aqr Capital Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 846,955 shares of UTHR stock, worth $233 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
846,955
Previous 551,767 53.5%
Holding current value
$233 Million
Previous $121 Million 60.36%
% of portfolio
0.33%
Previous 0.23%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$210.76 - $249.51 $62.2 Million - $73.7 Million
295,188 Added 53.5%
846,955 $195 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $16.2 Million - $19.3 Million
75,179 Added 15.77%
551,767 $121 Million
Q3 2023

Nov 14, 2023
SELL
$211.82 - $248.24 $7.2 Million - $8.44 Million
-34,013 Reduced 6.66%
476,588 $108 Million
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $28.2 Million - $32 Million
137,378 Added 36.81%
510,601 $113 Million
Q1 2023

May 15, 2023
BUY
$212.99 - $276.17 $24.1 Million - $31.3 Million
113,214 Added 43.54%
373,223 $83.6 Million
Q4 2022

Feb 14, 2023
SELL
$205.95 - $280.43 $7.02 Million - $9.56 Million
-34,079 Reduced 11.59%
260,009 $72.3 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $12 Million - $14.4 Million
-58,990 Reduced 16.71%
294,088 $61.3 Million
Q2 2022

Aug 15, 2022
SELL
$174.81 - $241.14 $4.08 Million - $5.62 Million
-23,313 Reduced 6.19%
353,078 $83.2 Million
Q1 2022

May 16, 2022
SELL
$166.16 - $213.96 $4.26 Million - $5.49 Million
-25,645 Reduced 6.38%
376,391 $66.1 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $9.14 Million - $10.7 Million
-49,571 Reduced 10.98%
402,036 $86.9 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $9.92 Million - $11.9 Million
-55,171 Reduced 10.89%
451,607 $83.4 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $20.5 Million - $25.5 Million
-120,489 Reduced 19.21%
506,778 $89.6 Million
Q1 2021

May 17, 2021
BUY
$153.94 - $174.85 $472,749 - $536,964
3,071 Added 0.49%
627,267 $105 Million
Q4 2020

Feb 16, 2021
SELL
$101.87 - $151.79 $32.5 Million - $48.4 Million
-318,854 Reduced 33.81%
624,196 $94.7 Million
Q3 2020

Nov 16, 2020
BUY
$99.9 - $121.13 $1.12 Million - $1.35 Million
11,178 Added 1.2%
943,050 $95.2 Million
Q2 2020

Aug 17, 2020
BUY
$92.74 - $125.82 $5.34 Million - $7.24 Million
57,566 Added 6.58%
931,872 $113 Million
Q1 2020

May 15, 2020
BUY
$79.39 - $115.35 $16.1 Million - $23.4 Million
203,177 Added 30.27%
874,306 $82.9 Million
Q4 2019

Feb 14, 2020
BUY
$78.31 - $95.34 $10.5 Million - $12.8 Million
133,916 Added 24.93%
671,129 $58.6 Million
Q3 2019

Nov 14, 2019
SELL
$74.85 - $85.99 $44.5 Million - $51.1 Million
-593,931 Reduced 52.51%
537,213 $42.8 Million
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $103 Million - $164 Million
-1,358,074 Reduced 54.56%
1,131,144 $87.6 Million
Q1 2019

May 14, 2019
SELL
$107.15 - $126.84 $2.72 Million - $3.21 Million
-25,345 Reduced 1.01%
2,489,218 $292 Million
Q4 2018

Feb 14, 2019
BUY
$101.4 - $128.73 $19 Million - $24.1 Million
187,196 Added 8.04%
2,514,563 $274 Million
Q3 2018

Nov 15, 2018
BUY
$113.81 - $129.46 $26.8 Million - $30.5 Million
235,459 Added 11.26%
2,327,367 $298 Million
Q2 2018

Aug 14, 2018
BUY
$101.14 - $118.31 $27.3 Million - $31.9 Million
269,437 Added 14.78%
2,091,908 $237 Million
Q1 2018

May 15, 2018
SELL
$107.21 - $151.94 $11.9 Million - $16.8 Million
-110,571 Reduced 5.72%
1,822,471 $205 Million
Q4 2017

Feb 14, 2018
SELL
$118.58 - $151.28 $29.3 Million - $37.4 Million
-246,958 Reduced 11.33%
1,933,042 $286 Million
Q3 2017

Nov 14, 2017
BUY
$114.6 - $136.81 $250 Million - $298 Million
2,180,000
2,180,000 $258 Million

Others Institutions Holding UTHR

# of Institutions
562
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $12.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email